TOL-3021 Placebo

OTHER3 trials

Sponsors

Tolerion, Inc.

Conditions

Diabetes Mellitus, Type 1

Phase 2

Diabetes AutoimmunitY Withdrawn in Established Patients (DAY)

WithdrawnNCT03794960

Tolerion, Inc.Diabetes Mellitus, Type 1

Start: 2019-12-14End: 2023-12-14Updated: 2020-12-08

Diabetes Autoimmunity Withdrawn in New Onset Patients (DAWN)

WithdrawnNCT03794973

Tolerion, Inc.Diabetes Mellitus, Type 1

Start: 2019-12-14End: 2023-12-14Updated: 2020-12-08

Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients

TerminatedNCT03895437

Tolerion, Inc.Diabetes Mellitus, Type 1

Start: 2019-06-17End: 2020-12-21Updated: 2026-05-20